These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 24861996)

  • 1. Association of ABCB1, CYP3A4, EPHX1, FAS, SCN1A, MICA, and BAG6 polymorphisms with the risk of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Chinese Han patients with epilepsy.
    He XJ; Jian LY; He XL; Tang M; Wu Y; Xu YY; Sun XJ; Zhao LM
    Epilepsia; 2014 Aug; 55(8):1301-6. PubMed ID: 24861996
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of EPHX1, SCN1A and CYP3A4 genetic polymorphisms on plasma carbamazepine concentrations and pharmacoresistance in Chinese patients with epilepsy.
    Yun W; Zhang F; Hu C; Luo X; Xue P; Wang J; Ge Y; Meng H; Guo Y
    Epilepsy Res; 2013 Dec; 107(3):231-7. PubMed ID: 24125961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China.
    He XJ; Jian LY; He XL; Wu Y; Xu YY; Sun XJ; Miao LY; Zhao LM
    Pharmacol Rep; 2013; 65(5):1256-62. PubMed ID: 24399721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABCB1 c.3435C > T and EPHX1 c.416A > G polymorphisms influence plasma carbamazepine concentration, metabolism, and pharmacoresistance in epileptic patients.
    Zhang ML; Chen XL; Bai ZF; Zhao X; Li WX; Wang XY; Zhang H; Chen XF; Zhang SQ; Tang JF; Xiao XH; Zhao YL
    Gene; 2021 Dec; 805():145907. PubMed ID: 34411648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the HLA-B alleles with carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype.
    Yuliwulandari R; Kristin E; Prayuni K; Sachrowardi Q; Suyatna FD; Menaldi SL; Wichukchinda N; Mahasirimongkol S; Cavallari LH
    Pharmacogenomics; 2017 Dec; 18(18):1643-1648. PubMed ID: 29053440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphic Variants of SCN1A and EPHX1 Influence Plasma Carbamazepine Concentration, Metabolism and Pharmacoresistance in a Population of Kosovar Albanian Epileptic Patients.
    Daci A; Beretta G; Vllasaliu D; Shala A; Govori V; Norata GD; Krasniqi S
    PLoS One; 2015; 10(11):e0142408. PubMed ID: 26555147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variants associated with severe cutaneous adverse drug reactions induced by carbamazepine.
    Nakkam N; Konyoung P; Amornpinyo W; Saksit N; Tiamkao S; Khunarkornsiri U; Khaeso K; Pattanacheewapull O; Jorns TP; Chumworathayi P; Tassaneeyakul W
    Br J Clin Pharmacol; 2022 Feb; 88(2):773-786. PubMed ID: 34350628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population.
    Chang CC; Too CL; Murad S; Hussein SH
    Int J Dermatol; 2011 Feb; 50(2):221-4. PubMed ID: 21244392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of major transporter and metabolizing enzyme gene polymorphisms on carbamazepine metabolism in Chinese patients with epilepsy.
    Zhu X; Yun W; Sun X; Qiu F; Zhao L; Guo Y
    Pharmacogenomics; 2014; 15(15):1867-79. PubMed ID: 25495409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between HLA and Stevens-Johnson syndrome induced by carbamazepine in Southern Han Chinese: genetic markers besides B*1502?
    Shi YW; Min FL; Qin B; Zou X; Liu XR; Gao MM; Wang Q; Zhou JQ; Liao WP
    Basic Clin Pharmacol Toxicol; 2012 Jul; 111(1):58-64. PubMed ID: 22348435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotype-phenotype association between HLA and carbamazepine-induced hypersensitivity reactions: strength and clinical correlations.
    Hsiao YH; Hui RC; Wu T; Chang WC; Hsih MS; Yang CH; Ho HC; Chang YG; Chen MJ; Lin JY; Chen DP; Chang PY; Wu TL; Hung SI; Chung WH
    J Dermatol Sci; 2014 Feb; 73(2):101-9. PubMed ID: 24268988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese.
    Hung SI; Chung WH; Liu ZS; Chen CH; Hsih MS; Hui RC; Chu CY; Chen YT
    Pharmacogenomics; 2010 Mar; 11(3):349-56. PubMed ID: 20235791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients.
    Zhang Y; Wang J; Zhao LM; Peng W; Shen GQ; Xue L; Zheng XX; He XJ; Gong CY; Miao LY
    Eur J Clin Pharmacol; 2011 Sep; 67(9):885-7. PubMed ID: 21424386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-B alleles associated with severe cutaneous reactions to antiepileptic drugs in Han Chinese.
    Cheung YK; Cheng SH; Chan EJ; Lo SV; Ng MH; Kwan P
    Epilepsia; 2013 Jul; 54(7):1307-14. PubMed ID: 23692434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Human Leukocyte Antigen Alleles with Carbamazepine- or Lamotrigine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in an Iranian Population: A Case-control Study.
    Dastgheib L; Rostami F; Gharesi-Fard B; Asadi-Pooya AA; Namjoo S; Tahmasebi F; Hadibarhaghtalab M
    Iran J Med Sci; 2023 Jan; 48(1):70-76. PubMed ID: 36688194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of EPHX1 and CYP3A4*22 genetic polymorphisms on carbamazepine metabolism and drug response among Tunisian epileptic patients.
    Chbili C; Fathallah N; Laouani A; Nouira M; Hassine A; Ben Amor S; Ben Ammou S; Ben Salem C; Saguem S
    J Neurogenet; 2016 Mar; 30(1):16-21. PubMed ID: 27276192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of polymorphisms in EPHX1, UGT2B7, ABCB1, ABCC2, SCN1A and SCN2A genes with carbamazepine therapy optimization.
    Hung CC; Chang WL; Ho JL; Tai JJ; Hsieh TJ; Huang HC; Hsieh YW; Liou HH
    Pharmacogenomics; 2012 Jan; 13(2):159-69. PubMed ID: 22188362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of carbamazepine major metabolism and transport pathway gene polymorphisms and pharmacokinetics in patients with epilepsy.
    Puranik YG; Birnbaum AK; Marino SE; Ahmed G; Cloyd JC; Remmel RP; Leppik IE; Lamba JK
    Pharmacogenomics; 2013 Jan; 14(1):35-45. PubMed ID: 23252947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between PK/PD-involved gene polymorphisms and carbamazepine-individualized therapy.
    Ma CL; Jiao Z; Wu XY; Hong Z; Wu ZY; Zhong MK
    Pharmacogenomics; 2015; 16(13):1499-512. PubMed ID: 26314341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population.
    Tassaneeyakul W; Tiamkao S; Jantararoungtong T; Chen P; Lin SY; Chen WH; Konyoung P; Khunarkornsiri U; Auvichayapat N; Pavakul K; Kulkantrakorn K; Choonhakarn C; Phonhiamhan S; Piyatrakul N; Aungaree T; Pongpakdee S; Yodnopaglaw P
    Epilepsia; 2010 May; 51(5):926-30. PubMed ID: 20345939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.